Venous thromboembolism (VTE) is the third most common cause of vascular mortality
worldwide and comprises deep-vein thrombosis (DVT) and pulmonary embolism (PE). In …

Background: The first objective of this review was to present, based on recent literature, the
most frequently applied medical options (oral contraceptive pills (OCPs) and progestogens) …

Wytyczne dotyczące nadciśnienia tętniczego opublikowane w 2013 r. przez Europejskie
Towarzystwo Nadciśnienia Tętniczego (ESH) i Europejskie Towarzystwo Kardiologiczne …

This guidance document focuses on the diagnosis and treatment of venous
thromboembolism (VTE). Efficient, cost effective diagnosis of VTE is facilitated by combining …

Background Combined oral contraceptives (COCs) have been associated with an increased
risk of arterial thrombosis, ie myocardial infarction or ischemic stroke. However, as these …

Background Women with medical conditions associated with increased risk for thrombosis
generally should not use estrogen-containing contraceptives; however, less is known about …

Venous thromboembolism (VTE) includes deep vein thrombosis and pulmonary embolism,
and a combination of environmental and genetic risk factors contributes to VTE risk. Within …

Background Oral contraceptives have been used by hundreds of millions of women around
the world. Important questions remain regarding the very long-term cancer risks that are …

Background Venous thromboses are well‐established complications of hormonal therapy.
Thrombosis risk is seen with both hormonal contraceptive agents and with hormone …

Estrogen and progestins have been used by millions of women as effective combined oral
contraceptives. Oral contraceptives (OCs) modify surrogate markers such as lipoproteins …